Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
391000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
New shares 391,000 shares / Treasury shares transferred 0 shares
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
The exercise price during the subject month ranged from ¥126 to ¥140. Details of the adjustment clause and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 100,000 rights; unexercised as of the end of the month preceding the subject month: 57,200 rights; unexercised as of the end of the subject month: 53,290 rights
Procedures under the Corporate Code of Conduct
The filing describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. The exercise ratio subject to the exercise restrictions was 1.8%.
Most recent equity financing
Timing Announced on 24 October 2025 and issued on 10 November 2025 / Type New shares issued through a third-party allotment, the 2025 Series 1 Stock Acquisition Rights (fixed exercise price), and the 2025 Series 2 Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | New shares 391,000 shares / Treasury shares transferred 0 shares |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Total number of issued shares | 27,564,392 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | The exercise price during the subject month ranged from ¥126 to ¥140. Details of the adjustment clause and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; unexercised as of the end of the month preceding the subject month: 57,200 rights; unexercised as of the end of the subject month: 53,290 rights |
| Procedures under the Corporate Code of Conduct | The filing describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. The exercise ratio subject to the exercise restrictions was 1.8%. |
| Most recent equity financing | Timing Announced on 24 October 2025 and issued on 10 November 2025 / Type New shares issued through a third-party allotment, the 2025 Series 1 Stock Acquisition Rights (fixed exercise price), and the 2025 Series 2 Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in June 2026 of the stock acquisition rights issued on 10 November 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.